Aptevo Therapeutics Inc.
eDR50Effective DR: 50/100. Below median. Measured by StartupHub.ai. Median 68.Agent33Agent Readiness: 33/100. Below median. Measured by StartupHub.ai. Median 41.A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.
About
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of various forms of cancer. They leverage their proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.
Similar companies
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, MedTech
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Shares Biotech, MedTech
Biotechnology company developing novel immunotherapies for cancer.
Shares Biotech, MedTech
Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
Shares Biotech, MedTech
Key facts
- Website
- aptevotherapeutics.com
- Headquarters
- Seattle, United States
- Founded
- 2016
- Business model
- B2B
Aptevo Therapeutics Inc. scores 31. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Aptevo Therapeutics Inc. do?
The company's pipeline includes clinical candidates for hematologic malignancies like acute myeloid leukemia and preclinical candidates for solid tumors.
What is Aptevo Therapeutics Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for Aptevo Therapeutics Inc. is 50 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 32, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Aptevo Therapeutics Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Aptevo Therapeutics Inc. is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Aptevo Therapeutics Inc.
